Wedbush reiterated their outperform rating on shares of Tenable (NASDAQ:TENB – Free Report) in a research report released on Thursday morning, Benzinga reports. Wedbush currently has a $65.00 target price on the stock. A number of other brokerages have also commented on TENB. Stephens lifted their price objective on Tenable from $60.00 to $62.00 and […]
Patrick Industries (NASDAQ:PATK – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Roth Mkm in a research note issued on Monday, Benzinga reports. They presently have a $126.00 price objective on the construction company’s stock, up from their prior price objective of $120.00. Roth Mkm’s target price suggests a potential […]
Needham & Company LLC reiterated their buy rating on shares of BILL (NYSE:BILL – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Needham & Company LLC currently has a $100.00 price target on the stock. A number of other equities research analysts have also weighed in on BILL. BNP […]
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Stifel Nicolaus assumed coverage on shares of Phathom Pharmaceuticals in a research report on Friday. They set […]
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a note issued to investors on Monday, Benzinga reports. They currently have a $22.00 price target on the stock. Needham & Company LLC’s price target would indicate a potential upside of 80.33% from the […]